+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Soft Tissue Repair Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011939
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Soft Tissue Repair Market is projected to reach USD 16.35 Billion in 2026. It is expected to continue growing at a CAGR of 5.41%, reaching USD 22.49 Billion by 2032.

Soft tissue repair covers surgical and nonsurgical solutions used to restore damaged fascia, tendons, ligaments, skin, muscle, and connective tissue. The market includes sutures, staples, surgical meshes, fixation devices, biologic and synthetic grafts, tissue sealants, hemostats, adhesion barriers, and regenerative matrices used across hernia repair, sports medicine, trauma, wound closure, pelvic reconstruction, and plastic surgery.

Demand is supported by verifiable healthcare trends: aging populations, higher prevalence of obesity and diabetes, increased musculoskeletal injuries, rising surgical volumes, and broader adoption of minimally invasive procedures. Industry growth depends on clinical evidence, biocompatibility, infection control, reimbursement access, and compliance with FDA, EU MDR, ISO 13485, and local medical device regulations.

Transformative Shifts in the Soft Tissue Repair Landscape

The soft tissue repair landscape is shifting from conventional closure products toward advanced biomaterials, resorbable scaffolds, biologic matrices, and hybrid devices designed to support stronger healing and reduce complications. Hospitals are also emphasizing products that shorten procedure time, support minimally invasive workflows, and demonstrate measurable clinical outcomes in areas such as hernia repair, tendon repair, ligament reconstruction, and advanced wound management.

Regulatory scrutiny, value-based procurement, and surgeon preference are reshaping competition. EU MDR requirements, FDA quality system expectations, unique device identification, and post-market surveillance obligations are increasing the importance of real-world evidence, traceability, sterility assurance, and supply resilience. Companies that combine innovation with documented safety, cost-effectiveness, and training support are best positioned for adoption.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is influencing soft tissue repair through imaging analytics, procedure planning, robotic surgery support, implant design, manufacturing quality control, and post-market safety monitoring. AI-enabled tools can help clinicians assess wound characteristics, stratify risks such as infection or delayed healing, and support more consistent decision-making when integrated with validated clinical workflows and physician oversight.

For manufacturers, AI can improve biomaterial design, demand planning, quality deviation detection, and analysis of real-world evidence from registries, claims, and electronic health records. Adoption must remain aligned with FDA guidance on software as a medical device, cybersecurity, data privacy, bias mitigation, clinical validation, and transparent performance monitoring across diverse patient populations.

Key Regional Insights

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN markets invest in surgical capacity, medical technology manufacturing, and hospital modernization. The region is also supported by aging populations in Japan and South Korea, high trauma and wound-care needs in large emerging economies, and increasing access to minimally invasive surgery in urban centers. North America remains a leading innovation and commercialization hub due to established reimbursement systems, high procedure volumes, active sports medicine demand, and strong FDA-regulated product development, with the United States and Canada emphasizing clinical evidence, infection prevention, and advanced hospital purchasing standards.

Latin America is shaped by access expansion in Brazil and Mexico, growing private hospital networks, and demand for reliable surgical meshes, wound closure systems, and fixation technologies. Europe is defined by high clinical standards, mature specialist surgery networks, and EU MDR-driven evidence requirements, while the United Kingdom operates under its own post-Brexit regulatory framework. The Middle East is advancing through specialty hospitals and healthcare infrastructure investment, particularly in GCC countries where complex surgery and premium medical technologies are prioritized. Africa shows long-term need linked to trauma care, wound management, burn treatment, and essential surgery access, though affordability, workforce capacity, and distribution remain key constraints.

Key Group Insights

ASEAN markets are benefiting from rising private healthcare investment, medical tourism, expanding hospital networks, and local distributor partnerships that support access to soft tissue repair products across wound closure, hernia repair, and orthopedic procedures. GCC countries are prioritizing advanced surgical specialties, premium hospital systems, procurement modernization, and healthcare localization programs, creating demand for clinically proven surgical repair technologies. The European Union remains a critical regulatory benchmark because EU MDR increases clinical evidence expectations, post-market surveillance requirements, and documentation standards for soft tissue repair devices and biologic-adjacent technologies.

BRICS economies are important demand centers because of population scale, surgical backlog, chronic disease burden, trauma incidence, and domestic manufacturing priorities, although reimbursement access and regional care disparities vary widely. G7 countries lead in premium product adoption, clinical research, regulatory rigor, and reimbursement sophistication, supporting early uptake of advanced biomaterials, minimally invasive tools, and evidence-backed wound care solutions. NATO members overlap with many high-income health systems where supply chain security, sterile manufacturing continuity, and trusted procurement partners are increasingly important for medical device availability and hospital preparedness.

Key Country Insights

The United States leads in product innovation, clinical trials, sports medicine, hernia repair, advanced wound care, and FDA-regulated medical device commercialization, while Canada emphasizes evidence-based procurement, public reimbursement, and hospital value analysis. Mexico and Brazil are key Latin American markets supported by private hospital growth, urban surgical capacity, and rising access to modern surgical meshes, sutures, hemostats, and wound closure products. The United Kingdom, Germany, France, Italy, and Spain remain major European markets shaped by specialist surgical networks, aging populations, hospital budget controls, and EU or UK medical device rules, with Germany and France maintaining strong roles in clinical evaluation and hospital-based adoption.

Russia continues to rely on domestic capacity and selective imports amid procurement localization and supply considerations, while China and India offer major volume opportunities supported by surgical demand, chronic disease burden, healthcare infrastructure expansion, and growing local manufacturing. Japan prioritizes quality, aging-related care, high clinical standards, and regulated adoption of advanced wound and reconstructive solutions. Australia has strong adoption of regulated devices supported by transparent health technology assessment and hospital procurement processes, and South Korea combines advanced hospitals, medtech innovation, high procedural expertise, and strong demand for orthopedic, reconstructive, and minimally invasive soft tissue repair procedures.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated products supported by comparative evidence, real-world outcomes, and clear economic value. Portfolio strategies should address high-volume procedures such as hernia repair, tendon and ligament repair, wound closure, trauma care, and reconstructive surgery while maintaining surgeon education, sterile supply reliability, and regulatory readiness.

Companies should also strengthen AI-enabled quality systems, post-market surveillance, complaint trend analysis, and demand forecasting without compromising validation, privacy, or cybersecurity. Partnerships with hospitals, contract manufacturers, distributors, and research institutions can accelerate market access, especially in Asia-Pacific, Latin America, and the Middle East, where training, affordability, and reliable logistics strongly influence adoption.

Research Methodology

This executive summary is developed using a structured secondary research approach based on publicly available and verifiable sources, including regulatory guidance from FDA and European authorities, healthcare expenditure references from OECD and World Bank sources, surgical safety priorities from WHO, and market-relevant clinical literature indexed in recognized biomedical databases.

Insights are synthesized through triangulation of procedure demand drivers, demographic trends, chronic disease indicators, medical device regulation, hospital purchasing behavior, and technology adoption patterns. The methodology emphasizes factual consistency, current industry context, and avoidance of unsupported claims, company-specific positioning, market sizing, market share, or market forecast assumptions.

Conclusion

Soft tissue repair is evolving into a technology-driven and evidence-led market where biomaterials, minimally invasive surgery, digital tools, and AI-enabled analytics are redefining product development and clinical adoption. Demand is reinforced by demographic pressure, chronic disease burden, sports injuries, trauma, wound care needs, and the continued clinical requirement for safe, durable tissue restoration.

Future success will depend on validated performance, regulatory compliance, cost-effectiveness, surgeon training, and regional. Organizations that align innovation with measurable patient outcomes, real-world evidence, and resilient supply chains will be better positioned to support sustainable growth across mature and emerging healthcare systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Soft Tissue Repair Market, by Product Type
7.1. Introduction
7.2. Fixation Devices
7.2.1. Interference Screws
7.2.2. Ligation Devices
7.2.3. Staples
7.2.4. Suture Anchors
7.3. Laparoscopic Instruments
7.4. Tissue Mesh/Patches
7.4.1. Biological Mesh
7.4.1.1. Allograft
7.4.1.2. Xenograft
7.4.2. Synthetic Mesh
8. Soft Tissue Repair Market, by Injury Type
8.1. Introduction
8.2. Acute Injury
8.3. Chronic Injury
9. Soft Tissue Repair Market, by Application
9.1. Introduction
9.2. Breast Reconstruction
9.3. Dental Soft Tissue Repair
9.4. Dural Repair
9.5. Hernia Repair
9.6. Orthopedic Repair
9.6.1. Anterior Cruciate Ligament Repair
9.6.2. Hip Labral Repair
9.6.3. Meniscal Repair
9.6.4. Rotator Cuff Repair
9.7. Skin Repair
9.8. Vaginal Sling Procedures
10. Soft Tissue Repair Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Research & Academic Institutes
10.5. Specialty Clinics
11. Soft Tissue Repair Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Soft Tissue Repair Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Soft Tissue Repair Market, by Country
13.1. United States
13.2. Germany
13.3. China
13.4. United Kingdom
13.5. India
13.6. Japan
13.7. Russia
13.8. Brazil
13.9. Canada
13.10. Italy
13.11. Mexico
13.12. France
13.13. Spain
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Aroa Biosurgery Limited
15.2. Arthrex, Inc.
15.3. Axogen Inc.
15.4. B. Braun Melsungen AG
15.5. Baxter International Inc.
15.6. Becton, Dickinson and Company
15.7. Boston Scientific Corporation
15.8. CONMED Corporation
15.9. CorMatrix Cardiovascular Inc.
15.10. Geistlich Pharma AG
15.11. Glycar SA Pty Ltd.
15.12. Henry Schein, Inc
15.13. Integra LifeSciences Holdings Corporation
15.14. Johnson & Johnson Services, Inc.
15.15. LifeNet Health, Inc.
15.16. Medtronic plc
15.17. Neoss AG
15.18. Organogenesis Inc.
15.19. Smith & Nephew plc
15.20. Stryker Corporation
15.21. Tissue Regenix Group Plc
15.22. W. L. Gore & Associates, Inc.
15.23. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL SOFT TISSUE REPAIR MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SOFT TISSUE REPAIR MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SOFT TISSUE REPAIR MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SOFT TISSUE REPAIR MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SOFT TISSUE REPAIR MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL SOFT TISSUE REPAIR MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SOFT TISSUE REPAIR MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL FIXATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL FIXATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL FIXATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL INTERFERENCE SCREWS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL INTERFERENCE SCREWS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL INTERFERENCE SCREWS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LIGATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LIGATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LIGATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL STAPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL STAPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL STAPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SUTURE ANCHORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SUTURE ANCHORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SUTURE ANCHORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL TISSUE MESH/PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL TISSUE MESH/PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL TISSUE MESH/PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICAL MESH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICAL MESH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICAL MESH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ALLOGRAFT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ALLOGRAFT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ALLOGRAFT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL XENOGRAFT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL XENOGRAFT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL XENOGRAFT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC MESH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC MESH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SYNTHETIC MESH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ACUTE INJURY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ACUTE INJURY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ACUTE INJURY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CHRONIC INJURY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CHRONIC INJURY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CHRONIC INJURY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DENTAL SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL DENTAL SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL DENTAL SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL DURAL REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DURAL REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DURAL REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL HERNIA REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ORTHOPEDIC REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ORTHOPEDIC REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ORTHOPEDIC REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ANTERIOR CRUCIATE LIGAMENT REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ANTERIOR CRUCIATE LIGAMENT REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ANTERIOR CRUCIATE LIGAMENT REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HIP LABRAL REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HIP LABRAL REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HIP LABRAL REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MENISCAL REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MENISCAL REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MENISCAL REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ROTATOR CUFF REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ROTATOR CUFF REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ROTATOR CUFF REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SKIN REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SKIN REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SKIN REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL VAGINAL SLING PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL VAGINAL SLING PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL VAGINAL SLING PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 121. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 122. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 123. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 124. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 125. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 126. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 127. EUROPE SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 139. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 140. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 141. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 142. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 143. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 144. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 145. AFRICA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 149. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 150. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 151. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 152. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 153. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 154. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 155. ASEAN SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. GCC SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. GCC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. GCC SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 159. GCC SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 160. GCC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 161. GCC SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 162. GCC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. GCC SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 164. GCC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 177. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 178. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 179. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 180. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 182. BRICS SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. G7 SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. G7 SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. G7 SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 186. G7 SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 187. G7 SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 188. G7 SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 189. G7 SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. G7 SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 191. G7 SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. NATO SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. NATO SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. NATO SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 195. NATO SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 196. NATO SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 197. NATO SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 198. NATO SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. NATO SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 200. NATO SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. GLOBAL SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 202. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 203. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 204. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. GERMANY SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 212. GERMANY SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 213. GERMANY SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 214. GERMANY SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 215. GERMANY SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 216. GERMANY SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 217. GERMANY SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 218. GERMANY SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 219. GERMANY SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. CHINA SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 221. CHINA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 222. CHINA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 223. CHINA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 224. CHINA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 225. CHINA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 226. CHINA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 227. CHINA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 228. CHINA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 233. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. INDIA SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. INDIA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. INDIA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 241. INDIA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 242. INDIA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 243. INDIA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 244. INDIA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. INDIA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 246. INDIA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 247. JAPAN SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. JAPAN SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 249. JAPAN SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 250. JAPAN SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 251. JAPAN SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 252. JAPAN SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 253. JAPAN SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. JAPAN SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 255. JAPAN SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 260. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 261. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 262. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 263. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 264. RUSSIA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 267. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 268. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 269. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 270. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 271. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 273. BRAZIL SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. CANADA SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 275. CANADA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 276. CANADA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 277. CANADA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 278. CANADA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 279. CANADA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 280. CANADA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 281. CANADA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 282. CANADA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. ITALY SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 284. ITALY SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 285. ITALY SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 286. ITALY SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 287. ITALY SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 288. ITALY SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 289. ITALY SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 290. ITALY SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 291. ITALY SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 292. MEXICO SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. MEXICO SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 294. MEXICO SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 295. MEXICO SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 296. MEXICO SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 297. MEXICO SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 298. MEXICO SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. MEXICO SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 300. MEXICO SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. FRANCE SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 302. FRANCE SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 303. FRANCE SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 304. FRANCE SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 305. FRANCE SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 306. FRANCE SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 307. FRANCE SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. FRANCE SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 309. FRANCE SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 310. SPAIN SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 311. SPAIN SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 312. SPAIN SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 313. SPAIN SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 314. SPAIN SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 315. SPAIN SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 316. SPAIN SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 317. SPAIN SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 318. SPAIN SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 321. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 322. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 323. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 324. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 325. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 326. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 327. AUSTRALIA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 328. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 329. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 330. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, BY FIXATION DEVICES, 2017-2032 (USD MILLION)
TABLE 331. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, BY TISSUE MESH/PATCHES, 2017-2032 (USD MILLION)
TABLE 332. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MESH, 2017-2032 (USD MILLION)
TABLE 333. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 334. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 335. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, BY ORTHOPEDIC REPAIR, 2017-2032 (USD MILLION)
TABLE 336. SOUTH KOREA SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 337. GLOBAL SOFT TISSUE REPAIR MARKET SHARE, BY KEY PLAYER, 2025
TABLE 338. GLOBAL SOFT TISSUE REPAIR MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Aroa Biosurgery Limited
  • Arthrex, Inc.
  • Axogen Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • CorMatrix Cardiovascular Inc.
  • Geistlich Pharma AG
  • Glycar SA Pty Ltd.
  • Henry Schein, Inc
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • LifeNet Health, Inc.
  • Medtronic plc
  • Neoss AG
  • Organogenesis Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Group Plc
  • W. L. Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.

Table Information